ResMed Inc. NYSE:RMD

Founder-led company

ResMed stock price today

$283.7
+50.51
+21.67%
Financial Health
0
1
2
3
4
5
6
7
8
9

ResMed stock price monthly change

+13.84%
month

ResMed stock price quarterly change

+13.84%
quarter

ResMed stock price yearly change

+34.80%
year

ResMed key metrics

Market Cap
33.04B
Enterprise value
34.65B
P/E
30.77
EV/Sales
7.20
EV/EBITDA
20.54
Price/Sales
7.12
Price/Book
6.59
PEG ratio
-38.61
EPS
6.51
Revenue
4.35B
EBITDA
1.41B
Income
957.71M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
23.15%
Oper. margin
29.5%
Gross margin
57.2%
EBIT margin
29.5%
EBITDA margin
32.42%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

ResMed stock price history

ResMed stock forecast

ResMed financial statements

Average Price Target
Last Year

$233.5

Potential downside: -17.69%

Based on estimate of 4 analysts
  • Analysts Price target

  • Financials & Ratios estimates

ResMed Inc. (NYSE:RMD): Profit margin
Jun 2022 914.73M 195.06M 21.32%
Mar 2023 1.11B 232.5M 20.82%
Jun 2023 1.12B 229.66M 20.47%
Mar 2024 1.19B 300.49M 25.1%
ResMed Inc. (NYSE:RMD): Earnings per share (EPS)
2024-10-24 2.04 2.2
0.86%
Yield TTM
ResMed Inc. (NYSE:RMD): Payout ratio
Payout ratio 26.02%
ResMed Inc. (NYSE:RMD): Dividend Yield
2020 0.81%
2021 0.63%
2022 0.8%
2023 0.81%
2024 1.03%
ResMed Inc. (NYSE:RMD): Debt to assets
Dec 2022 6676104000 2.93B 44.01%
Mar 2023 6713879000 2.78B 41.43%
Jun 2023 6751708000 2.62B 38.83%
Mar 2024 6814562000 2.18B 32.06%
ResMed Inc. (NYSE:RMD): Cash Flow
Jun 2022 79.48M -55.24M 57.49M
Mar 2023 282.56M -28.10M -279.55M
Jun 2023 237.43M -46.52M -188.59M
Mar 2024 402.03M -33.15M -335.91M

ResMed alternative data

ResMed Inc. (NYSE:RMD): Employee count
Aug 2023 8,160
Sep 2023 10,140
Oct 2023 10,140
Nov 2023 10,140
Dec 2023 10,140
Jan 2024 10,140
Feb 2024 10,140
Mar 2024 10,140
Apr 2024 10,140
May 2024 10,140
Jun 2024 10,140
Jul 2024 10,140

ResMed other data

64.79% -0.55%
of RMD is owned by hedge funds
95.21M -852.64K
shares is hold by hedge funds

ResMed Inc. (NYSE:RMD): Insider trades (number of shares)
Period Buy Sel
Feb 2024 0 10935
Mar 2024 0 281
Apr 2024 0 425
May 2024 0 28043
Jun 2024 0 15683
Jul 2024 0 15683
Aug 2024 0 74565
Sep 2024 0 22683
Oct 2024 0 21943
Nov 2024 0 26708
Dec 2024 0 3074
Transaction Date Insider Security Shares Price per share Total value Source
Sale
SANDERCOCK BRETT officer: Chief Fi.. ResMed Common Stock 1,000 $244.23 $244,230
Sale
SANDERCOCK BRETT officer: Chief Fi.. ResMed Common Stock 1,000 $244.23 $244,230
Sale
FARRELL PETER C director
ResMed Common Stock 2,000 $245.65 $491,300
Sale
RIDER MICHAEL J officer: Global General Counsel
ResMed Common Stock 74 $248.91 $18,419
Sale
FARRELL MICHAEL J. officer: Chief Ex.. ResMed Common Stock 2,000 $249.67 $499,330
Sale
LEONG JUSTIN officer: Chief Product Officer
ReMed Common Stock 6,160 $243.09 $1,497,416
Sale
DE WITTE JAN director
ReMed Common Stock 796 $248.81 $198,053
Sale
SANDERCOCK BRETT officer: Chief Fi.. ResMed Common Stock 1,000 $249 $249,000
Sale
SANDERCOCK BRETT officer: Chief Fi.. ResMed Common Stock 1,000 $249 $249,000
Option
FARRELL MICHAEL J. officer: Chief Ex.. ResMed Common Stock 14,683 $84.98 $1,247,761
Patent
Application
Filling date: 16 Feb 2022 Issue date: 18 Aug 2022
Application
Filling date: 24 Jul 2020 Issue date: 4 Aug 2022
Application
Filling date: 28 Apr 2020 Issue date: 23 Jun 2022
Grant
Filling date: 7 Sep 2020 Issue date: 21 Jun 2022
Grant
Filling date: 31 Jul 2015 Issue date: 21 Jun 2022
Application
Filling date: 3 Mar 2022 Issue date: 16 Jun 2022
Application
Filling date: 23 Feb 2022 Issue date: 9 Jun 2022
Grant
Filling date: 31 Jul 2015 Issue date: 24 May 2022
Application
Filling date: 13 Jan 2022 Issue date: 5 May 2022
Application
Filling date: 26 Jun 2020 Issue date: 28 Apr 2022
Insider Compensation
Mr. Michael J. Farrell BE, MBA, SM (1972) Chief Executive Officer & Director
$2,690,000
Mr. Robert A. Douglas (1960) Pres & Chief Operating Officer $1,940,000
Dr. James R. Hollingshead Ph.D. (1963) Pres of Sleep & Respiratory Care Bus. $1,430,000
Mr. Brett A. Sandercock (1967) Chief Financial Officer $1,010,000
Dr. Peter C. Farrell A.M., AM, B.E., BE (Hons), Ph.D., ScD (1942) Founder & Non-Executive Chairman
$441,460
Monday, 23 December 2024
investopedia.com
zacks.com
schaeffersresearch.com
zacks.com
Friday, 20 December 2024
zacks.com
Friday, 13 December 2024
zacks.com
Thursday, 12 December 2024
zacks.com
zacks.com
Monday, 9 December 2024
zacks.com
zacks.com
Wednesday, 4 December 2024
zacks.com
globenewswire.com
Tuesday, 3 December 2024
zacks.com
Monday, 2 December 2024
seekingalpha.com
Tuesday, 26 November 2024
zacks.com
Monday, 25 November 2024
zacks.com
Thursday, 21 November 2024
zacks.com
Wednesday, 20 November 2024
zacks.com
Friday, 15 November 2024
zacks.com
Friday, 8 November 2024
zacks.com
Tuesday, 5 November 2024
globenewswire.com
Monday, 4 November 2024
zacks.com
zacks.com
Sunday, 3 November 2024
seekingalpha.com
Tuesday, 29 October 2024
zacks.com
youtube.com
Monday, 28 October 2024
zacks.com
zacks.com
zacks.com
Saturday, 26 October 2024
investors.com
  • What's the price of ResMed stock today?

    One share of ResMed stock can currently be purchased for approximately $283.7.

  • When is ResMed's next earnings date?

    ResMed Inc. is estimated to report earnings on Wednesday, 22 Oct 2025.

  • Does ResMed pay dividends?

    Yes, ResMed pays dividends and its trailing 12-month yield is 0.87% with 26% payout ratio. The last ResMed stock dividend of $0.42 was paid on 17 Mar 2022.

  • How much money does ResMed make?

    ResMed has a market capitalization of 33.04B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 10.95% to 4.69B US dollars. ResMed earned 1.02B US dollars in net income (profit) last year or $2.2 on an earnings per share basis.

  • What is ResMed's stock symbol?

    ResMed Inc. is traded on the NYSE under the ticker symbol "RMD".

  • What is ResMed's primary industry?

    Company operates in the Healthcare sector and Medical - Instruments & Supplies industry.

  • How do i buy shares of ResMed?

    Shares of ResMed can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are ResMed's key executives?

    ResMed's management team includes the following people:

    • Mr. Michael J. Farrell BE, MBA, SM Chief Executive Officer & Director(age: 53, pay: $2,690,000)
    • Mr. Robert A. Douglas Pres & Chief Operating Officer(age: 65, pay: $1,940,000)
    • Dr. James R. Hollingshead Ph.D. Pres of Sleep & Respiratory Care Bus.(age: 62, pay: $1,430,000)
    • Mr. Brett A. Sandercock Chief Financial Officer(age: 58, pay: $1,010,000)
    • Dr. Peter C. Farrell A.M., AM, B.E., BE (Hons), Ph.D., ScD Founder & Non-Executive Chairman(age: 83, pay: $441,460)
  • Is ResMed founder-led company?

    Yes, ResMed is a company led by its founder Dr. Peter C. Farrell A.M., AM, B.E., BE (Hons), Ph.D., ScD.

  • How many employees does ResMed have?

    As Jul 2024, ResMed employs 10,140 workers.

  • When ResMed went public?

    ResMed Inc. is publicly traded company for more then 30 years since IPO on 2 Jun 1995.

  • What is ResMed's official website?

    The official website for ResMed is resmed.com.

  • Where are ResMed's headquarters?

    ResMed is headquartered at 9001 Spectrum Center Boulevard, San Diego, CA.

  • How can i contact ResMed?

    ResMed's mailing address is 9001 Spectrum Center Boulevard, San Diego, CA and company can be reached via phone at 858 836 5000.

  • What is ResMed stock forecast & price target?

    Based on 4 Wall Street analysts` predicted price targets for ResMed in the last 12 months, the avarage price target is $233.5. The average price target represents a -17.69% change from the last price of $283.7.

ResMed company profile:

ResMed Inc.

resmed.com
Exchange:

NYSE

Full time employees:

9,980

Industry:

Medical - Instruments & Supplies

Sector:

Healthcare

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME)to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; and HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies. The company markets its products primarily to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

9001 Spectrum Center Boulevard
San Diego, CA 92123

CIK: 0000943819
ISIN: US7611521078
CUSIP: 761152107